Log in to save to my catalogue

ECM1 attenuates hepatic fibrosis by interfering with mediators of latent TGF-β1 activation

ECM1 attenuates hepatic fibrosis by interfering with mediators of latent TGF-β1 activation

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3120147461

ECM1 attenuates hepatic fibrosis by interfering with mediators of latent TGF-β1 activation

About this item

Full title

ECM1 attenuates hepatic fibrosis by interfering with mediators of latent TGF-β1 activation

Publisher

England: BMJ Publishing Group Ltd and British Society of Gastroenterology

Journal title

Gut, 2025-03, Vol.74 (3), p.424-439

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd and British Society of Gastroenterology

More information

Scope and Contents

Contents

ObjectiveExtracellular matrix protein 1 (ECM1) serves as a gatekeeper of hepatic fibrosis by maintaining transforming growth factor-β1 (TGF-β1) in its latent form. ECM1 knockout (KO) causes latent (L) TGF-β1 activation, resulting in hepatic fibrosis with rapid mortality. In chronic liver disease (CLD), ECM1 decreases with increasing CLD severity. W...

Alternative Titles

Full title

ECM1 attenuates hepatic fibrosis by interfering with mediators of latent TGF-β1 activation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_3120147461

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3120147461

Other Identifiers

ISSN

0017-5749,1468-3288

E-ISSN

1468-3288

DOI

10.1136/gutjnl-2024-333213

How to access this item